Literature DB >> 26141259

Sepsis-induced acute kidney injury in patients with cirrhosis.

Paolo Angeli1, Marta Tonon2, Chiara Pilutti2, Filippo Morando2, Salvatore Piano2.   

Abstract

Acute kidney injury (AKI) is a common and life-threatening complication in patients with cirrhosis. Recently, new criteria for the diagnosis of AKI have been proposed in patients with cirrhosis by the International Club of Ascites. Almost all types of bacterial infections can induce AKI in patients with cirrhosis representing its most common precipitating event. The bacterial infection-induced AKI usually meets the diagnostic criteria of hepatorenal syndrome (HRS). Well in keeping with the "splanchnic arterial vasodilation hypothesis", it has been stated that HRS develops as a consequence of a severe reduction of effective circulating volume related to splanchnic arterial vasodilation and to an inadequate cardiac output. Nevertheless, the role of bacterial infections in precipitating organ failures, including renal failure, is enhanced when their course is characterized by the development of a systemic inflammatory response syndrome (SIRS), thus, when sepsis occurs. Sepsis has been shown to be capable to induce "per se" AKI in animals as well as in patients conditioning also the features of renal damage. This observation suggests that when precipitated by sepsis, the pathogenesis and the clinical course of AKI also in patients with cirrhosis may differentiate to a certain extent from AKI with another or no precipitating factor. The purpose of this review is to describe the features of AKI precipitated by bacterial infections and to highlight whether infection and/or the development of SIRS may influence its clinical course, and, in particular, the response to treatment.

Entities:  

Keywords:  Acute kidney injury; Acute on chronic liver failure; Albumin; Bacterial infections; Biomarkers; Hepatorenal syndrome; Sepsis; Terlipressin

Mesh:

Substances:

Year:  2015        PMID: 26141259     DOI: 10.1007/s12072-015-9641-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  40 in total

1.  New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Authors:  Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

Review 2.  A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

Authors:  Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

3.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

Authors:  Paolo Angeli; Pere Gines; Florence Wong; Mauro Bernardi; Thomas D Boyer; Alexander Gerbes; Richard Moreau; Rajiv Jalan; Shiv K Sarin; Salvatore Piano; Kevin Moore; Samuel S Lee; Francois Durand; Francesco Salerno; Paolo Caraceni; W Ray Kim; Vicente Arroyo; Guadalupe Garcia-Tsao
Journal:  Gut       Date:  2015-01-28       Impact factor: 23.059

4.  Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.

Authors:  Mónica Guevara; Carlos Terra; André Nazar; Elsa Solà; Javier Fernández; Marco Pavesi; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-06-23       Impact factor: 25.083

5.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

6.  Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.

Authors:  Silvano Fasolato; Paolo Angeli; Lucia Dallagnese; Giulio Maresio; Erika Zola; Elena Mazza; Freddy Salinas; Silvio Donà; Stefano Fagiuoli; Antonietta Sticca; Giacomo Zanus; Umberto Cillo; Ilaria Frasson; Carla Destro; Angelo Gatta
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

7.  Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.

Authors:  Claudia Fagundes; Marie-Noëlle Pépin; Mónica Guevara; Rogelio Barreto; Gregori Casals; Elsa Solà; Gustavo Pereira; Ezequiel Rodríguez; Elisabet Garcia; Verónica Prado; Esteban Poch; Wladimiro Jiménez; Javier Fernández; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

8.  Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis.

Authors:  Dara De las Heras; Javier Fernández; Pere Ginès; Andres Cárdenas; Rolando Ortega; Miguel Navasa; Joan Albert Barberá; Blas Calahorra; Mónica Guevara; Ramón Bataller; Wladimiro Jiménez; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

9.  Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.

Authors:  Dominique Thabut; Julien Massard; Alice Gangloff; Nicolas Carbonell; Claire Francoz; Eric Nguyen-Khac; Christian Duhamel; Didier Lebrec; Thierry Poynard; Richard Moreau
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

Authors:  Arun J Sanyal; Thomas Boyer; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Andres Blei; Veit Gülberg; Samuel Sigal; Peter Teuber
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

View more
  6 in total

Review 1.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

2.  SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis.

Authors:  R Maiwall; S S Chandel; Z Wani; S Kumar; S K Sarin
Journal:  Dig Dis Sci       Date:  2015-10-15       Impact factor: 3.199

Review 3.  Management of ascites and hepatorenal syndrome.

Authors:  Salvatore Piano; Marta Tonon; Paolo Angeli
Journal:  Hepatol Int       Date:  2017-08-23       Impact factor: 6.047

4.  Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.

Authors:  Maria Papp; Tamas Tornai; Zsuzsanna Vitalis; Istvan Tornai; David Tornai; Tamas Dinya; Andrea Sumegi; Peter Antal-Szalmas
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

5.  Association of FIB-4 index and clinical outcomes in critically ill patients with acute kidney injury: a cohort study.

Authors:  Yi-Yi Shi; Rui Zheng; Jie-Jie Cai; Zheng-Dong Fang; Wen-Jing Chen; Jing-Ye Pan; Song-Zan Qian
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

6.  Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis.

Authors:  Xiaofeng Shi; Yue Zhang; Hao Wang; Sha Zeng
Journal:  Med Sci Monit       Date:  2017-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.